+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Human liver mephenytoin 4'-hydroxylase cytochrome P-450 proteins and genes



Human liver mephenytoin 4'-hydroxylase cytochrome P-450 proteins and genes



Drug Metabolism Reviews 20(2-4): 449-465




(PDF emailed within 0-6 h: $19.90)

Accession: 040314211

Download citation: RISBibTeXText

PMID: 2680390

DOI: 10.3109/03602538909103552


Related references

Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry 27(18): 6929-6940, 1988

Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Molecular Pharmacology 40(1): 69-79, 1991

A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450. Analytical Biochemistry 147(1): 174-179, 1985

Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry 26(4): 1094-1099, 1987

In vitro inhibition studies of 2 isozymes of human liver cytochrome p 450 mephenytoin p hydroxylase and sparteine monooxygenase. Drug Metabolism & Disposition 13(4): 443-448, 1985

In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase. Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(4): 443-448, 1985

Anticancer drugs as inhibitors of two polymorphic cytochrome p 450 enzymes debrisoquine and mephenytoin hydroxylase in human liver microsomes. Cancer Research 49(1): 68-71, 1989

In vitro inhibition studies of 2 distinct isozymes of human liver cytochrome p 450 mephenytoin p hydroxylase and sparteine monooxygenase. Federation Proceedings 44(5): 1466, 1985

Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation. Biochimica et Biophysica Acta 884(3): 435-447, 1986

Human liver microsomal cytochrome p 450 mephenytoin 4 hydroxylase a prototype of genetic polymorphism in oxidative drug metabolism purification and characterization of two similar forms involved in the reaction. Journal of Biological Chemistry 261(2): 909-921, 1986

Genetic polymorphism of human cytochrome p 450 s mephenytoin 4 hydroxylase studies with human autoantibodies suggest a functionally altered cytochrome p 450 isozyme as cause of the genetic deficiency. Biochemistry 26(25): 8466-8474, 1987

Alterations in human CYP2C19, the major S-mephenytoin 4-hydroxylase, in poor metabolizers of S-mephenytoin. FASEB Journal 8(7): A1257, 1994

Mephenytoin hydroxylase activity in human liver: inhibition by steroids. Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(6): 746-749, 1985

Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes. Journal of Pharmacology and Experimental Therapeutics 240(1): 216-222, 1987

Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metabolism and Disposition: the Biological Fate of Chemicals 24(5): 610-614, 1996